Report Detail

Pharma & Healthcare Global Alzheimer’s Therapeutics Market Professional Survey Report 2019

  • RnM3743526
  • |
  • 13 September, 2019
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Alzheimer’s Therapeutics Market Professional Survey Report 2019

Table of Contents

    Executive Summary

      1 Industry Overview of Alzheimer’s Therapeutics

      • 1.1 Definition of Alzheimer’s Therapeutics
      • 1.2 Alzheimer’s Therapeutics Segment by Type
        • 1.2.1 Global Alzheimer’s Therapeutics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Donepezil
        • 1.2.3 Memantine
        • 1.2.4 Rivastigmine
      • 1.3 Alzheimer’s Therapeutics Segment by Applications
        • 1.3.1 Global Alzheimer’s Therapeutics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Early to Moderate Stages
        • 1.3.3 Moderate to Severe Stages
      • 1.4 Global Alzheimer’s Therapeutics Overall Market
        • 1.4.1 Global Alzheimer’s Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Alzheimer’s Therapeutics Production (2014-2025)
        • 1.4.3 North America Alzheimer’s Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 Europe Alzheimer’s Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 China Alzheimer’s Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Japan Alzheimer’s Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Alzheimer’s Therapeutics Status and Prospect (2014-2025)
        • 1.4.8 India Alzheimer’s Therapeutics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Alzheimer’s Therapeutics
      • 2.3 Manufacturing Process Analysis of Alzheimer’s Therapeutics
      • 2.4 Industry Chain Structure of Alzheimer’s Therapeutics

      3 Development and Manufacturing Plants Analysis of Alzheimer’s Therapeutics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Alzheimer’s Therapeutics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Alzheimer’s Therapeutics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Alzheimer’s Therapeutics Production and Capacity Analysis
      • 4.2 Alzheimer’s Therapeutics Revenue Analysis
      • 4.3 Alzheimer’s Therapeutics Price Analysis
      • 4.4 Market Concentration Degree

      5 Alzheimer’s Therapeutics Regional Market Analysis

      • 5.1 Alzheimer’s Therapeutics Production by Regions
        • 5.1.1 Global Alzheimer’s Therapeutics Production by Regions
        • 5.1.2 Global Alzheimer’s Therapeutics Revenue by Regions
      • 5.2 Alzheimer’s Therapeutics Consumption by Regions
      • 5.3 North America Alzheimer’s Therapeutics Market Analysis
        • 5.3.1 North America Alzheimer’s Therapeutics Production
        • 5.3.2 North America Alzheimer’s Therapeutics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Alzheimer’s Therapeutics Import and Export
      • 5.4 Europe Alzheimer’s Therapeutics Market Analysis
        • 5.4.1 Europe Alzheimer’s Therapeutics Production
        • 5.4.2 Europe Alzheimer’s Therapeutics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Alzheimer’s Therapeutics Import and Export
      • 5.5 China Alzheimer’s Therapeutics Market Analysis
        • 5.5.1 China Alzheimer’s Therapeutics Production
        • 5.5.2 China Alzheimer’s Therapeutics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Alzheimer’s Therapeutics Import and Export
      • 5.6 Japan Alzheimer’s Therapeutics Market Analysis
        • 5.6.1 Japan Alzheimer’s Therapeutics Production
        • 5.6.2 Japan Alzheimer’s Therapeutics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Alzheimer’s Therapeutics Import and Export
      • 5.7 Southeast Asia Alzheimer’s Therapeutics Market Analysis
        • 5.7.1 Southeast Asia Alzheimer’s Therapeutics Production
        • 5.7.2 Southeast Asia Alzheimer’s Therapeutics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Alzheimer’s Therapeutics Import and Export
      • 5.8 India Alzheimer’s Therapeutics Market Analysis
        • 5.8.1 India Alzheimer’s Therapeutics Production
        • 5.8.2 India Alzheimer’s Therapeutics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Alzheimer’s Therapeutics Import and Export

      6 Alzheimer’s Therapeutics Segment Market Analysis (by Type)

      • 6.1 Global Alzheimer’s Therapeutics Production by Type
      • 6.2 Global Alzheimer’s Therapeutics Revenue by Type
      • 6.3 Alzheimer’s Therapeutics Price by Type

      7 Alzheimer’s Therapeutics Segment Market Analysis (by Application)

      • 7.1 Global Alzheimer’s Therapeutics Consumption by Application
      • 7.2 Global Alzheimer’s Therapeutics Consumption Market Share by Application (2014-2019)

      8 Alzheimer’s Therapeutics Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer Alzheimer’s Therapeutics Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer Alzheimer’s Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Merck &
        • 8.2.1 Merck & Alzheimer’s Therapeutics Production Sites and Area Served
        • 8.2.2 Merck & Product Introduction, Application and Specification
        • 8.2.3 Merck & Alzheimer’s Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Novartis AG
        • 8.3.1 Novartis AG Alzheimer’s Therapeutics Production Sites and Area Served
        • 8.3.2 Novartis AG Product Introduction, Application and Specification
        • 8.3.3 Novartis AG Alzheimer’s Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Eisai
        • 8.4.1 Eisai Alzheimer’s Therapeutics Production Sites and Area Served
        • 8.4.2 Eisai Product Introduction, Application and Specification
        • 8.4.3 Eisai Alzheimer’s Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 H. Lundbeck A/S
        • 8.5.1 H. Lundbeck A/S Alzheimer’s Therapeutics Production Sites and Area Served
        • 8.5.2 H. Lundbeck A/S Product Introduction, Application and Specification
        • 8.5.3 H. Lundbeck A/S Alzheimer’s Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 AC Immune
        • 8.6.1 AC Immune Alzheimer’s Therapeutics Production Sites and Area Served
        • 8.6.2 AC Immune Product Introduction, Application and Specification
        • 8.6.3 AC Immune Alzheimer’s Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 TauRx Pharmaceuticals
        • 8.7.1 TauRx Pharmaceuticals Alzheimer’s Therapeutics Production Sites and Area Served
        • 8.7.2 TauRx Pharmaceuticals Product Introduction, Application and Specification
        • 8.7.3 TauRx Pharmaceuticals Alzheimer’s Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Actavis plc.
        • 8.8.1 Actavis plc. Alzheimer’s Therapeutics Production Sites and Area Served
        • 8.8.2 Actavis plc. Product Introduction, Application and Specification
        • 8.8.3 Actavis plc. Alzheimer’s Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Forest Laboratories
        • 8.9.1 Forest Laboratories Alzheimer’s Therapeutics Production Sites and Area Served
        • 8.9.2 Forest Laboratories Product Introduction, Application and Specification
        • 8.9.3 Forest Laboratories Alzheimer’s Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Teva Pharmaceuticals Industries
        • 8.10.1 Teva Pharmaceuticals Industries Alzheimer’s Therapeutics Production Sites and Area Served
        • 8.10.2 Teva Pharmaceuticals Industries Product Introduction, Application and Specification
        • 8.10.3 Teva Pharmaceuticals Industries Alzheimer’s Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Janssen Pharmaceutical
      • 8.12 GE healthcare
      • 8.13 Eli Lilly And Company
      • 8.14 DiaGenic ASA
      • 8.15 VTV Therapeutics
      • 8.16 Hoffman-La Roche
      • 8.17 AstraZeneca
      • 8.18 Daiichi Sankyo Company

      9 Development Trend of Analysis of Alzheimer’s Therapeutics Market

      • 9.1 Global Alzheimer’s Therapeutics Market Trend Analysis
        • 9.1.1 Global Alzheimer’s Therapeutics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Alzheimer’s Therapeutics Regional Market Trend
        • 9.2.1 North America Alzheimer’s Therapeutics Forecast 2019-2025
        • 9.2.2 Europe Alzheimer’s Therapeutics Forecast 2019-2025
        • 9.2.3 China Alzheimer’s Therapeutics Forecast 2019-2025
        • 9.2.4 Japan Alzheimer’s Therapeutics Forecast 2019-2025
        • 9.2.5 Southeast Asia Alzheimer’s Therapeutics Forecast 2019-2025
        • 9.2.6 India Alzheimer’s Therapeutics Forecast 2019-2025
      • 9.3 Alzheimer’s Therapeutics Market Trend (Product Type)
      • 9.4 Alzheimer’s Therapeutics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Alzheimer’s Therapeutics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
        Europe is estimated to grow at a rapid pace owing to the high prevalence of AD coupled with ever improving diagnostic capabilities. Asia Pacific is expected to witness the fastest growth over the forecast period owing to the rising disposable income level.

        The global Alzheimer’s Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Alzheimer’s Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alzheimer’s Therapeutics market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Alzheimer’s Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Alzheimer’s Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer
        Merck &
        Novartis AG
        Eisai
        H. Lundbeck A/S
        AC Immune
        TauRx Pharmaceuticals
        Actavis plc.
        Forest Laboratories
        Teva Pharmaceuticals Industries
        Janssen Pharmaceutical
        GE healthcare
        Eli Lilly And Company
        DiaGenic ASA
        VTV Therapeutics
        Hoffman-La Roche
        AstraZeneca
        Daiichi Sankyo Company

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Donepezil
        Memantine
        Rivastigmine

        Segment by Application
        Early to Moderate Stages
        Moderate to Severe Stages


        Summary:
        Get latest Market Research Reports on Alzheimer’s Therapeutics. Industry analysis & Market Report on Alzheimer’s Therapeutics is a syndicated market report, published as Global Alzheimer’s Therapeutics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Alzheimer’s Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,802.38
        4,203.58
        5,604.77
        3,166.44
        4,749.66
        6,332.88
        378,084.00
        567,126.00
        756,168.00
        249,460.75
        374,191.13
        498,921.50
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report